Induction of Inflammatory Arthropathy Resembling Rheumatoid Arthritis in Mice Transgenic for HTLV-I
- 30 August 1991
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 253 (5023) , 1026-1028
- https://doi.org/10.1126/science.1887217
Abstract
Human T cell leukemia virus type-I (HTLV-I) is the etiologic agent of adult T cell leukemia and has also been suggested to be involved in other diseases such as chronic arthritis or myelopathy. To elucidate pathological roles of the virus in disease, transgenic mice were produced that carry the HTLV-I genome. At 2 to 3 months of age, many of the mice developed chronic arthritis resembling rheumatoid arthritis. Synovial and periarticular inflammation with articular erosion caused by invasion of granulation tissues were marked. These observations suggest a possibility that HTLV-I is one of the etiologic agents of chronic arthritis in humans.Keywords
This publication has 27 references indexed in Scilit:
- Production of interleukin-1β-like factor with synovial cell growth promoting activity from adult T-cell leukemia cellsJournal of Autoimmunity, 1991
- Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritisArthritis & Rheumatism, 1990
- Chronic acquired immunodeficiency syndrome‐associated arthritis: a synovial ultrastructural studyArthritis & Rheumatism, 1990
- Differential effects on expression of IL‐2 receptors (p55 and p70) by the HTLV‐I pX DNAInternational Journal of Cancer, 1988
- The tat Gene of Human T-Lymphotropic Virus Type 1 Induces Mesenchymal Tumors in Transgenic MiceScience, 1987
- A Transgenic Mouse Model for Human NeurofibromatosisScience, 1987
- Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40x and T3/Ti complex triggeringCell, 1987
- A spontaneous rheumatoid arthritis-like disease in MRL/l mice.The Journal of Experimental Medicine, 1982
- Mycoplasma infections as models of chronic joint inflammationArthritis & Rheumatism, 1979
- History of a Case of Hydrophobia, treated at the Hotel Dieu at Paris, by an injection of water into the veins.The Lancet, 1823